Henry Schein | HSIC - Ebitda


Henry Schein reported $288M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Agilent USD 577M 77M Jun/2026
Align Technology USD 229.14M 31.74M Mar/2026
Bruker USD 143.2M 33.2M Jun/2026
Cardinal Health USD 955M 135M Jun/2026
Charles River Laboratories USD 272.95M 43.14M Jun/2026
Cigna USD 3.28B 416M Mar/2026
Cooper Companies USD 67.9M 255.5M Mar/2026
CVS Health USD 5.85B 25M Jun/2026
Danaher USD 1.84B 81M Jun/2026
Dentsply International USD 190M 61M Jun/2026
Encompass Health USD 348M 800K Jun/2026
Henry Schein USD 288M 1000K Jun/2026
Idexx Laboratories USD 468.46M 67.59M Jun/2026
IQVIA Holdings USD 994M 62M Jun/2026
Laboratory Of America USD 767.7M 162.1M Jun/2026
McKesson USD 1.71B 674M Jun/2026
Mettler Toledo International USD 322.64M 43.66M Jun/2026
Owens Minor USD 90.02M 2.15M Dec/2025
Quest Diagnostics USD 648M 91M Jun/2026
Revvity USD 228.18M 44.73M Jun/2026
Stryker USD 1.93B 357M Jun/2026
Tenet Healthcare USD 1.3B 142M Jun/2026
Thermo Fisher Scientific USD 3.55B 845M Jun/2026
Universal Health Services USD 677.87M 17.36M Jun/2026
Veradigm USD 38.81M 29.61M Sep/2022
Waters USD 712M 545M Jun/2026
Zimmer Biomet Holdings USD 830.5M 190.4M Jun/2026
Zoetis USD 939M 0 Mar/2026